Clinical trial
Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
NCT00411411 · University Hospital, Gentofte, Copenhagen, Other · Completed
Key facts
| NCT number | NCT00411411 |
|---|---|
| Title | Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes |
| Official title | Phase 3, Double Blinded, Placebo Controlled Study of the Effects of 12 Weeks DPP-IV Inhibitor Treatment on Secretion and Action of the Incretin Hormones in Patients With Type 2 Diabetes |
| Lead sponsor | University Hospital, Gentofte, Copenhagen, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Januvia, Placebo |
| Enrollment | 49 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Dec 14, 2006 |
| Last update posted | Aug 13, 2014 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: